eComID
eComID, backed by H&M Group, offers AI-powered infrastructure to enable personalization in online fashion retail. The company positions itself as a 'shopping passport' that aims to address persistent challenges in e-commerce, particularly around size uncertainty and high return rates, by providing shopper-specific insights from the first visit.
Public-source profile · Company ownership not verified. Sources & corrections
The short feature · 2 min read
eComID, at a glance
Built for · Online fashion brands, e-commerce managers, and digital retail decision-makers seeking to reduce return rates, improve conversion, and implement…
Based on company material. Product claims are attributed to the company.
- 01
The problem
Fashion e-commerce faces high return rates, often exceeding 30%, due to size uncertainty and generic product discovery. Brands struggle to personalize shopping experiences from the first visit, leading to multi-size purchases ('bracketing') and lost revenue from returned items.
Sources [1]
- 02
The product approach
eComID provides AI-driven tools embedded in a brand’s digital storefront, including size recommendations, conversational search, and personalized product curation. The platform creates a 'shopping passport' that carries a shopper’s size, style, and preference data across brands, enabling one-to-one personalization from the first visit.
Sources [1]
- 03
What stands out
Unlike generic recommendation engines, eComID claims to deliver personalization from the first interaction by leveraging a shopper’s cross-brand profile. It also introduces dynamic return policies based on individual shopper behavior, such as 'eComID Score,' which adjusts return fees according to a shopper’s return history.
Sources [1]
What could be hard to replicate?
A useful product is not automatically a moat. These mechanisms need evidence of a lasting advantage.
Data advantage
Company claimCross-brand shopper profile: eComID aggregates size, style, and preference data into a persistent 'shopping passport' that follows shoppers across participating brands, enabling personalization from the first visit.
Mechanism → evidence check
Does exclusive data improve the product in a way competitors cannot reproduce?
Sources [1]
Technology & IP
Company claimCollaborative sizing logic: The platform standardizes size recommendations across brands using shared intelligence, reducing bracketing and returns by guiding shoppers to the 'right size' instantly.
Mechanism → evidence check
What prevents another team from reproducing the capability?
Sources [1]
Network effects
Company claimNetwork effects via connected brands: eComID’s value increases as more brands adopt it, as shoppers benefit from consistent personalization across a broader range of stores.
Mechanism → evidence check
Does each additional participant make the product more useful for others?
Sources [1]
The question to watch
What evidence shows that customers choose this product over alternatives, and keep using it?
Explore the evidence · 1 source
- [1] eComID company website
Company material · checked 5/10/2026
o r e c a n b e . 0m Monthly users Globally, 20m shoppers use eComID every month. 0% Lower return rate eComID shoppers…
About
H&M-backed eComID is building the AI infrastructure to democratize personalization in commerce.
Profile sources, ownership & corrections
Company ownership is not verified
This profile was compiled from public sources and hasn't been verified by eComID. Claim it to correct the details, add your team and funding history, and request review of your company information.
Compiled from news coverage, the company's own website.
Similar startups
AI3D Studio — ai3d.studio
AI3D Studio is a browser-based platform that converts 2D inputs—such as photos, text prompts, sketches.
SignSplit is a platform designed to allow individuals and institutions to manage their data, work, and likeness by enabling protection, licensing.
Decart is an AI lab developing real-time world models designed to operate at millisecond latency.
Isomorphic Labs is a company applying artificial intelligence to drug discovery.